Q32 Bio Inc QTTB 深 沪
已收盘 07-02 16:00:00 美东时间
13.09
+0.490
+3.89%
华盛通- 最 高13.30
- 今 开12.68
- 成交量 16.27万股
- 最 低 12.54
- 昨 收 12.60
- 总市值 2.22亿
- 52周最高 15.02
- 市盈率 静 5.41
- 换手率 0.96%
- 52周最低 1.5685
- 委 比 1.02%
- 总股本 1695.64万
- 历史最高 572.40
- 量 比 0.37
- 振 幅 6.03%
- 历史最低 1.345
- 每 手 1
- 风险率 3.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Is Q32 Bio Stock Gaining Friday?
Q32 Bio ($QTTB) jumps in premarket trading after securing a $55M private placement to fund its autoimmune pipeline. Read more.
05-29 22:10
美股牛股 | VTIX飙升46%，获美国空军SBIR项目资金支持；360数科大涨25%
VTIX飙升46%，获美国空军SBIR项目资金支持；APPS大涨38%，财报强劲，美银称其增长前景清晰；360数科大涨25%，用户规模稳步扩容，信贷投放有所收缩>>
05-28 19:22
Q32 Bio Inks Securities Purchase Agreement With New, Current Institutional Investors For ~$55M Private Placement Of Common Stock, Pre-Funded Warrants
Q32 Bio Inc. (NASDAQ:QTTB) ("Q32 Bio" or "Company"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, today
05-27 20:04
Cantor Fitzgerald Initiates Coverage On Q32 Bio with Overweight Rating
Cantor Fitzgerald initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Overweight rating.
05-18 23:19
美股大行评级 | Stifel上调Lumentum控股目标价从800美元升至1100美元；Pinterest、先进能源工业、安森美半导体、莱迪思半导体、V2X等获多家大行上调目标价
今日重点评级关注：Piper Sandler：维持Aclaris Therapeutics"超配"评级，目标价从7美元升至11美元；Evercore ISI集团：维持BioMarin Pharmaceutical"跑赢大市"评级，目标价从110美元升至120美元
05-06 11:29
HC Wainwright & Co. Reiterates Buy on Q32 Bio, Maintains $13 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Q32 Bio (NASDAQ:QTTB) with a Buy and maintains $13 price target.
05-06 00:14
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Q32 Bio Q1 EPS $(0.54) Beats $(0.68) Estimate
Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.68) by 20.59 percent. This is a 40 percent increase over losses of $(0.90) per share from the same
05-05 19:09
Why Organon Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Organon & Co (OGN) jumped 14.8% in pre-market trading as Sun Pharma agreed to acquire the company for $11.75 billion, $2 higher than current price.
04-27 16:45
美股夜盘 | Homology Medicines, Inc.跌20.58%，最新股价4.94美元
Homology Medicines, Inc.跌20.58%，报4.94美元
04-27 10:01
